Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Phase 1 Completed
145 enrolled
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Phase 1 Completed
31 enrolled
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
Phase 1 Completed
17 enrolled
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
Phase 1 Completed
64 enrolled
GEN2
Phase 1 Completed
61 enrolled
OPTIM
Phase 1 Completed
13 enrolled
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Phase 1 Completed
24 enrolled
Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
Phase 1 Completed
15 enrolled
DUET-3
Phase 1 Completed
198 enrolled
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Phase 1 Completed
146 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Phase 1 Completed
46 enrolled
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Phase 1 Completed
128 enrolled 27 charts
NAC to Prevent Cisplatin-induced Hearing Loss
Phase 1 Completed
52 enrolled
DUET-4
Phase 1 Completed
78 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
DUET-2
Phase 1 Completed
150 enrolled
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Phase 1 Completed
174 enrolled 68 charts
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
Phase 1 Completed
120 enrolled
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
Phase 1 Completed
17 enrolled
Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients
Phase 1 Completed
20 enrolled
Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Phase 1 Completed
10 enrolled
Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
Phase 1 Completed
30 enrolled 16 charts
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Phase 1 Completed
22 enrolled 15 charts
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Phase 1 Completed
21 enrolled
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery
Phase 1 Completed
24 enrolled
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Phase 1 Completed
25 enrolled
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
Phase 1 Completed
24 enrolled
LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis
Phase 1 Completed
9 enrolled
MEDI-573-1028
Phase 1 Completed
6 enrolled 15 charts
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
Phase 1 Completed
13 enrolled
Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Phase 1 Completed
13 enrolled
TKM 080301 for Primary or Secondary Liver Cancer
Phase 1 Completed
1 enrolled
Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer
Phase 1 Completed
20 enrolled
STA-9090 in Patients With Advanced Hepatocellular Cancer
Phase 1 Completed
16 enrolled
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Phase 1 Completed
11 enrolled
A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
Phase 1 Completed
28 enrolled
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Phase 1 Completed
14 enrolled
Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
Phase 1 Completed
12 enrolled
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase 1 Completed
28 enrolled
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
7 enrolled
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer
Phase 1 Completed
18 enrolled
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
Phase 1 Completed
47 enrolled 8 charts
Hepatic Arterial Infusion (HAI) of Abraxane
Phase 1 Completed
64 enrolled
Spectroscopy With Surface Coils and Decoupling
Phase 1 Completed
582 enrolled
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
Phase 1 Completed
115 enrolled
PeproStat Haemostat Study in Subjects Undergoing Liver Surgery
Phase 1 Completed
20 enrolled
Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
Phase 1 Completed
34 enrolled